AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Ashley House Plc
Ashley House Plc (LON:ASH) is a High Wycombe, United Kingdom based construction and materials company that is involved in the business of design supply, construction management as well as consulting services.
ASH Trading Update
On 31st January 2020, the company provided a trading update. It was reported that the company is still operating on its revised strategy, after the interest from the Morgan Ashley division was sold in October, which was the development of property schemes and programmes in the affordable housing sector. The company is also focusing on development of schemes in the health as well as wellbeing segment. It has been reported in the trading statement that significant progress has been made in association with the major institutional purchasers of affordable housing as well as with landowners to develop an efficient and viable pipeline of affordable housing programmes.
The company has also highlighted that the results for the 18 months period ended 31st October 2019 will be reported by the end of the month of March 2020. The results are expected to depict a loss for the mentioned 18 months period, and will also incorporate all transactional activities from the sale of Morgan Ashley.
ASH Stock Price Performance
(Source: Thomson Reuters) Daily Chart as on 31-January-20, before the closing of the LSE Market
As on 31st January 2020, at 2:00 P.M (Greenwich Mean Time), by the time of writing this report, the Ashley House Plc Stock was trading at a price of GBX 2.65 per stock on the London Stock Exchange market, no change in the price of the stock, from the previous trading day. The market capitalisation (M-Cap) of the stock stood at a value of GBP 1.62 million, with respect to the current market price of the stock of the company at the time of writing this report.
It has been reported that the Ashley House Plc stock had lost around 75.46 per cent in value, in the last twelve months, since January 31, 2019, when the stock was trading at a price of GBX 10.80 per stock at the time of the close of the market. It has also been reported that the companyâs stock has lost approximately 66.03 per cent, in the last six months, in comparison with the stock price of GBX 7.80 at the time of the close of the market as on July 31, 2019.
The beta of the Ashley House Plcâs stock has been reported to be at -0.27, giving an idea that the movement in the stock price is inversely correlated with the movement of the comparative benchmark index.
Hargreaves Lansdown Plc
A Bristol, the United Kingdom based Financial services company Hargreaves Lansdown Plc (LON: HL.) is engaged in providing investment as well as wealth management services.
Half Year Report
The organisation issued a press release for the purpose of announcing its interim results for the six months ended 31st December 2019, on 31st January 2020. The company primarily highlighted that net new business for the period stood at £2.31 billion, a decline of 9 per cent year on year as opposed to H1 FY 2019 when net new business stood at a value of £2.53 billion. Net New Business is basically a term used for prospective customers who have been transformed into paying customers by the company. The company also reported a 22 per cent increase in the Total Assets under Administration, which were reported at £105.2 billion as on 31st December 2019, as opposed to £85.9 billion as on 31st December 2018. The revenue for the period also increased by 9 per cent year on year during the period to £257.9 million in H1 FY 2020 from £236.4 million in H1 FY 2019. The profit before tax for the period was reported to be at a growth of 12 per cent year on year from £153.4 million in H1 FY 2019 to £171.1 million in H1 FY 2020. The diluted earnings per share increase by 12 per cent to GBX 29.3 per share in H1 FY 2020 from GBX 26.1 per share in H1 FY 2019. As a reflection of this excellent performance during the year, the board of the company proposed an interim dividend at a growth of 9 per cent year on year to GBX 11.2 per share in H1 FY 2020.
Stock Price Performance
(Source: Thomson Reuters) Daily Chart as on 31-January-20, before the closing of the LSE Market
As on 31st January 2020, at 2:07 P.M (Greenwich Mean Time), by the time of writing this report, the Hargreaves Lansdown Plc stock was trading at a price of GBX 1760.70 per stock on the London Stock Exchange market, a decline in the value of 6.32 per cent or GBX 118.80 per stock, as opposed to the price of the stock on the previous trading day, which had been reported to be at GBX 1879.50 per stock. The market capitalisation (M-Cap) of the stock stood at a value of GBP 8.914 billion, with respect to the current market price of the stock of the company at the time of writing this report.
It has been reported that the Hargreaves Lansdown Plc stock had gained around 7.82 per cent in value, in the last twelve months, since January 31, 2019, when the stock was trading at a price of GBX 1633.00 per stock at the time of the close of the market. It has also been reported that the companyâs stock has lost approximately 16.16 per cent, in the last six months, in comparison with the stock price of GBX 2100.00 at the time of the close of the market as on July 31, 2019.
The beta of the Hargreaves Lansdown Plcâs stock has been reported to be at 1.30, giving an idea that the movement in the stock price, is more volatile, as against the movement of the comparative benchmark index.
Scancell Holdings Plc
Scancell Holdings Plc (LON:SCLP) is a pharmaceuticals and Biotechnology company based out of Oxford, the United Kingdom, majorly engaged in the developing treatment mechanism for cancer therapeutics.
SCLP Interim Results
On 31st January 2020, the organisation reported its half yearly results for the six months ended 31st October 2019. The primary highlighting point of the result was the fact that the company signed three collaboration agreements (one of which was after the end of the reporting period) for its new proprietary AvidiMab⢠technology platform. The company incurred a loss of £3.09 million for H1 FY 2020, a decline, in comparison with the loss reported during H1 FY 2019 of £3.68 million. As on 31st October 2019, the cash balance of the company on its books was reported to be at £5.79 million. This was an increase in the cash balance as compared to 1st April 2019, when the cash was reported to be at £4.56 million during the period, symbolising the inflow of cash within the reporting period. The company reported that the basic and diluted loss per share for the period stood at a value of GBX 0.56 per share, as opposed to GBX 0.84 per share at the end of H1 FY 2019.
SCLP Stock Price Performance
(Source: Thomson Reuters) Daily Chart as on 31-January-20, before the closing of the LSE Market
As on 31st January 2020, at 2:12 P.M (Greenwich Mean Time), by the time of writing this report, the Scancell Holdings Plc stock was trading at a price of GBX 6.945 per stock on the London Stock Exchange market, a decline in the value of 0.79 per cent or GBX 0.055 per stock, as opposed to the price of the stock on the previous trading day, which had been reported to be at GBX 7.00 per stock. The market capitalisation (M-Cap) of the stock stood at a value of GBP 32.57 million, with respect to the current market price of the stock of the company at the time of writing this report.
It has been reported that the Scancell Holdings Plc stock had lost around 7.40 per cent in value, in the last twelve months, since January 31, 2019, when the stock was trading at a price of GBX 7.50 per stock at the time of the close of the market. It has also been reported that the companyâs stock has lost approximately 18.29 per cent, in the last six months, in comparison with the stock price of GBX 8.50 at the time of the close of the market as on July 31, 2019.
The beta of the Scancell Holdings Plcâs stock has been reported to be at 0.34, giving an idea that the movement in the stock price, is less fickle, as against the movement of the comparative benchmark index.
